The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 HiTech Pharmacal Co. Inc.  (HITK) Trade Now »     Rate HITK  -  Discuss HITK  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
33.0%
Top:
0.0%
Rate HITK:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

HITK: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

look for HITK to double in value......trailing PE is no longer relevant Graphic_rating_buy HITK
N/A
 -6.69%
in 67 days
<> <> I am a CPA veteran and stock analysis enthusiast that has been actively researching and following HITK for a long time.  Sales, margins, and net profits for the company are growing off the charts over the past 6 months. They appear to have quietly arrived in the generic drug industry as a competitor on a new level. The company's trailing PE of 15 includes $1.5M earnings for the 2nd and 3rd qtrs of the prior fiscal year........but these amounts don't appear very relevant considering consecutive record breaking quarters of $5M and $8M earnings for the more recent 4th qtr of last year and t<><><><><><><><><><><><><><>...
By  toddschaus   (-6.69%  risk: conservative)  09/16/09 Comment


New Indexes to Track Healthcare Trends and More Graphic_rating_buy HITK
Mikerun
73%
 +26.88%
in 110 days

Below are links and descriptions for 23 new stock indexes I have created, revised, and tracked over the past few years which are now featured at a new website called Investars YOU. The new site includes automated index tracking, allows investors to create custom stock portfolios based on their individual preferences, and now features free access to all of the component stocks in each of my indexes. Some of the top performing stocks from my healthcare indexes on a year-to-date basis are highlighted below.

Cosmetic & Restorative Medicine Index: Allergan (NYSE:AGN) (+38%)

<> The <> ...
By  Mike Havrilla   (+1.04%  risk: conservative)  08/04/09 Comment


Big Pharma Goes Generic Graphic_rating_buy HITK
Mikerun
73%
 +185.34%
in 159 days
(closed on 08/04/09)
Big Pharma Goes Generic edit
<> <> <> <> <> <> Sanofi-Aventis (SNY) is now the 11 th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVent...
By  Mike Havrilla   (+1.04%  risk: conservative)  02/26/09 Comment


Hi-Tech Pharmacal: Hi-Growth at a Value Price Graphic_rating_buy HITK
Mikerun
73%
 +13.19%
in 29 days
(closed on 02/26/09)
Hi-Tech Pharmacal: Hi-Growth at a Value Price
 
With shares of Home Diagnostics (HDIX) surging by nearly 50% since I profiled the company in mid-December as a turnaround, value play from the ETF Innovators Healthcare Cost Containment Index ; a search for compelling values among these companies today led me to generic drug maker Hi-Tech Pharmacal (HITK).
 
<> Shares of HITK are down by about 10% in the past five days on light volume and no news headlines, providing a nice chance to accumulate some shares. The Company reported record quarterly revenue for i...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/28/09 Comment


Healthcare Hot Spots Beyond Stem Cells Graphic_rating_buy HITK
Mikerun
73%
 +0.21%
in 2 days
(closed on 01/28/09)
Beyond Stem Cells: Healthcare Hot Spots
 
With the surprise announcement last week by Geron (GERN) that the FDA would allow human clinical trials for embryonic stem cells, all companies in the underlying ETF Innovators Index to track the space are screaming higher again today – led by the company with the biggest gains over the past year, StemCells (STEM).
 
 
<> Below are three additional areas and associated companies for investors to consider in the search of the next hot s...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/26/09 Comment




From the Blogosphere

Generic Drug Makers

Here’s another terrific post by Pharmboy, this time discussing Generic Drug Makers. - Ilene

Generic Drug Makers

Variety of Pills

<script type="text/javascript" src="http://cdn.pis.picapp.com/IamProd/PicAppPIS/JavaScript/PisV4.js"></script>

Courtesy of Pharmboy

Coming to the end of a good year, and good riddance for some!  Whilst the market has been irrational for some time, it is not about what we think but rather about what others that have money think.  I have my notions, and here are a few companies that may do well in the New Year with a passed health care reform bill.

<>I really like the generic market ri...
By  Philip Davis   (+0.00%)  11/10/09 Comment


Mylan: Generic Drugmaker with a Strong Portfolio
<>Mylan Pharmaceuticals (MYL) keeps coming up on my radar so I would like to take the time to analyze the stock and give some recommendations on it. Mylan is approaching its 52 week high so is it a buy or not? In October 2008, they reached a 52 week low of 5.75 and today is trading at 14.88. So that old adage of Buy Low-Sell High is coming into play. In these economic times many rules of trading are finding exceptions to that rule. Mylan's Financial picture can be found on Google Finance here. I see a good exception to Mylan's future, and see the company's stock rising based on FDA approvals ...
By  trackseekingalpha   (-11.47%  risk: aggressive)  08/28/09 Comment


Big Pharma Goes Generic
Mikerun
73%
Sanofi-Aventis (SNY) is now the 11th largest generic drug maker in the world following its successful acquisition of Czech generic drug company Zentiva. As $70B in brand drug patents are set to expire through 2012, big pharma companies are hedging their bets through generic drug divisions, including Pfizer (PFE) - Greenstone, Novartis (NVS) - Sandoz, and the recently announced Merck (MRK) BioVentures which will specialize in bio-generics.

Elsewhere in the industry, India-based Ranbaxy (RANBAXY.NS) lost about 20% of its market value today on word the FDA would not review new generic drug prod...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/08/09 Comment


A 130/30 Pharma Trade
Mikerun
73%
<>The accompanying tables (click to enlarge either) include 12 U.S. listed companies from the ETF Innovators Global Generic Drug Index along with eight brand drug companies, which are ranked in descending order based on their patent expiration exposure through the end of 2011 as a percentage of total trailing 12-month revenue.

Investors who are bullish on the generic drug industry may consider implementing a 130/30 pharma trade by shorting any/all of the top seven brand drug companies by patent expiration exposure with 30% of their assets while investing 130% of assets in long positions among ...
By  Mike Havrilla   (+1.04%  risk: conservative)  02/20/09 Comment


Caraco Pharma Awaits FDA Inspection
Mikerun
73%
With shares of Hi-Tech Pharmacal (HITK) already up about 20% since I profiled the Company as a value play two days ago, investors interested in the small-cap generic drug industry should take a look at Caraco Pharma (CPD) today at around 5 bucks. CPD reported results for its fiscal 3Q09 yesterday, including $55.7M in revenue and net income of $5.1M, which was down from the year-ago period revenue of $81.9M and net income of $10.8M. The year-ago period benefited substantially from the 180-day exclusivity period associated with the generic drug launch of oxcarbazepine (Trileptal) in conjuncti...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/30/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 378
2 Gerald Greene 18.14 +70.10% 208
3 stockmarketfunding.com 17.66 +25.70% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment
WFC Wells Fargo & Company
LEH Lehman Brothers Holdings Inc
BA The Boeing Company
INTC Intel Corp
RIMM Research in Motion Ltd
ETFC E*Trade Financial Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on HITK

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About HiTech Pharmacal Co. Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch